CRP and kidney cancer: In this study, using data from the UK Biobank cohort, with a longer follow-up compared to the earlier reports [11, 13, 18], we have examined the associations of inflammatory markers (represented by individual leucocyte subtype counts − neutrophil, monocyte, and lymphocyte counts, and CRP) and platelet parameters (platelet count, MPV, and PDW) with kidney cancer risk.